CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2006; 27(01): 6-7
DOI: 10.1055/s-0041-1733143
Editorial

Incidence and clinical implications of Epstein-Barr Virus-associated Hodgkin's Lymphoma

Veronique Dinand
Department of Paediatrics, All India Institute of Medical Sciences, New Delhi, India
› Author Affiliations


Publication History

Article published online:
23 March 2022

© 2006. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Rajalakshmi T, Payal K, Purnima Makhija, Karuna V. Epstein-Barr virus in Hodgkin's lymphoma - Incidence and prognostic implications. Ind J Med Paed Oncol 2006;27:23-26.
  • 2 Radha K, Shanthi P, Madhavan M, Senthamarai A. Study of association of Epstein-Barr virus with Hodgkin's disease. Ind J Pathol Microbiol 1997;40(3):351-354.
  • 3 Naresh KN, Johnson J, Srinivas V, et al. Epstein-Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells. Ann Oncol 2000;11:91-96.
  • 4 Karnik S, Srinivasan B, Nair S. Hodgkin's lymphoma: immunohistochemical features and its association with EBV LMP-1. Experience from a South Indian hospital. Pathology. 2003;35(3):207-211.
  • 5 Dinand V, Arya LS, Dawar R. Prevalence and significance of Epstein-Barr virus latent membrane protein-1 detection in Hodgkin's and Reed-Sternberg cells. Ind J Med Res 2005;121(Suppl):157 (abstract).
  • 6 Glaser SL, Lin RJ, Stewart SL, et al. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer 1997;70:375-382.
  • 7 Dinand V, Arya LS. Epidemiology of childhood Hodgkin's disease: is it different in developing countries? Indian Pediatr 2006;43(2):141-147.
  • 8 Murray PG, Billingham LJ, Hassan HT, et al. Effects of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's disease. Blood 1999;94(2):442-447.
  • 9 Montalban C, Abraira V, Morente M, et al. Epsteinbarr virus-latent membrane protein 1 expression has a favorable influence in the outcome of patients with Hodgkin's disease treated with chemotherapy. Leuk Lymphoma 2000;39(5-6):563-572.
  • 10 Stark GL, Wood KM, Jack F, Angus B, Proctor SJ, Taylor PR; Northern Region Lymphoma Group. Hodgkin's disease in the elderly: a population-based study. Br J Haematol. 2002;119(2):432-440.
  • 11 Jarrett RF, Stark GL, White J, et al. Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study. Blood 2005;106(7):2444-2451.
  • 12 Hasenclever D, Diehl V: A Prognostic score for Advanced Hodgkin's Disease. N Engl J Med 1998;339:1506-1514.